EBR vs NAN

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

EBR

EBR SYSTEM CDI FORUS [EBR]

48LOW

NAN

NANOSONICS FPO [NAN]

48LOW

Score Breakdown

EBR NAN
Technical
35
66
Catalyst
51
50
Sentiment
50
50
Fundamental
66
87
Momentum
33
41
Risk Gate
46
40

Key Metrics

EBR Metric NAN
$292.8MMarket Cap$1.1B
476KAvg Volume (20d)1.1M
+0.0%Short Interest+11.9%
$2.08052-Week High$5.080
$0.64052-Week Low$3.210
-2.3%Daily Change+1.9%
$0.650Entry Price$3.700
-195.3%ROE+10.1%
N/AProfit Margin+9.9%

Active Signals

EBR Signals

RSI drifting toward oversold territory — worth watching
Trading below both moving averages — the trend is working against this one
Above-average volume (1.6x) on a red day — sellers in control
Drifting lower — down 8.5% over the last 5 days
Below the 200-day average — the long-term trend is still working against it
Low cash runway (4 quarters) - dilution risk
4C filed 2026-03-18
Very high P/S ratio (181.1x)

NAN Signals

MACD momentum is picking up steam
Knocking on the door of resistance — if it punches through, things could get interesting
Beating the Small Ords index — relative strength of 1.21, so it's outpacing the pack
Volume-price trend suggests distribution — sellers may be sneaking out while price holds
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Moderate P/S ratio (5.4x)

Ask Scout AI to compare EBR and NAN in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
EBR Full Analysis → NAN Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).